Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
27 Februar 2024 - 1:00PM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a
biopharmaceutical company focused on discovering, developing, and
commercializing important new medicines to improve the lives of
people with cancer, today announced that members of the management
team will participate in fireside chats at the following investor
conferences:
- TD Cowen 44th Annual Health Care Conference on Tuesday, March
5, 2024 at 1:30 PM ET in Boston, MA
- Leerink Partners Global Biopharma Conference on Monday, March
11, 2024 at 2:40 PM ET in Miami Beach, FL
- Barclays Global Healthcare Conference on Wednesday, March 13,
2024 at 8:00 AM ET in Miami Beach, FL
Live webcasts will be available on the “Events and
Presentations” page in the “Investors” section of the Company’s
website at https://investors.deciphera.com/events-presentations.
All webcast replays will be archived on the Company’s website for
90 days following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing, and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
switch-control inhibitor for the treatment of fourth-line GIST.
QINLOCK is approved in Australia, Canada, China, the European
Union, Hong Kong, Iceland, Israel, Liechtenstein, Macau, New
Zealand, Norway, Singapore, Switzerland, Taiwan, The United
Kingdom, and the United States. For more information, visit
https://www.deciphera.com/ and follow us on LinkedIn and X
(@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227371221/en/
Investor Relations: Maghan Meyers Argot Partners
Deciphera@argotpartners.com 212-600-1902
Media: David Rosen Argot Partners
david.rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Mai 2023 bis Mai 2024